相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
G. Bug et al.
LEUKEMIA (2017)
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats
David Brocks et al.
NATURE GENETICS (2017)
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
Bas J. Wouters et al.
BLOOD (2016)
Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy
Pragya Srivastava et al.
ONCOTARGET (2016)
Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis
Vincent van den Boom et al.
CELL REPORTS (2016)
Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2
Takeshi Ueda et al.
BLOOD (2015)
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Herve Dombret et al.
BLOOD (2015)
DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
Olga Grishina et al.
BMC CANCER (2015)
The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells
Gabriele Greve et al.
BMC CANCER (2015)
5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft
J. Steinmann et al.
BONE MARROW TRANSPLANTATION (2015)
PRMT5 inhibitors as novel treatment for cancers
Hendrik Falk et al.
CANCER RESEARCH (2015)
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
David Roulois et al.
CELL (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
Nicole Stopa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
DNA demethylation by 5-aza-2′-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences
Maria-Paz Ramos et al.
EPIGENETICS & CHROMATIN (2015)
The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells
Y-S Lai et al.
BLOOD CANCER JOURNAL (2015)
Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression
R. Mitchell Baldwin et al.
ONCOTARGET (2015)
Inferring regulatory element landscapes and transcription factor networks from cancer methylomes
Lijing Yao et al.
GENOME BIOLOGY (2015)
Combining DNA Methyltransferase and Histone Deacetylase Inhibition to Treat Acute Myeloid Leukemia/Myelodysplastic Syndrome: Achievements and Challenges
Michael Luebbert et al.
CANCER (2015)
A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome
Mark Kirschbaum et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang et al.
CANCER CELL (2014)
Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905
Thomas Prebet et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
H. Yang et al.
LEUKEMIA (2014)
DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML
Kirstin Lund et al.
GENOME BIOLOGY (2014)
Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer
Marta Kulis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
Genomic impact of transient low-dose decitabine treatment on primary AML cells
Jeffery M. Klco et al.
BLOOD (2013)
Dynamic DNA methylation across diverse human cell lines and tissues
Katherine E. Varley et al.
GENOME RESEARCH (2013)
Functional DNA demethylation is accompanied by chromatin accessibility
Kurinji Pandiyan et al.
NUCLEIC ACIDS RESEARCH (2013)
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
Metin Karahoca et al.
CLINICAL EPIGENETICS (2013)
Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma
Song Gu et al.
ANTI-CANCER DRUGS (2012)
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research
N. Shenker et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
The H3K4me3 Histone Demethylase Fbxl10 Is a Regulator of Chemokine Expression, Cellular Morphology, and the Metabolome of Fibroblasts
Andreas Janzer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Hagop M. Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding
A. Ptasinska et al.
LEUKEMIA (2012)
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL
Matko Kalac et al.
BLOOD (2011)
KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia
Jin He et al.
BLOOD (2011)
Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate-or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
Michael Luebbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO
J. Duque-Afonso et al.
ONCOGENE (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells
Maika Almstedt et al.
LEUKEMIA RESEARCH (2010)
Conserved role of intragenic DNA methylation in regulating alternative promoters
Alika K. Maunakea et al.
NATURE (2010)
Non-intensive treatment with low-dose 5-aza-2′-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients
M. Luebbert et al.
BONE MARROW TRANSPLANTATION (2009)
The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells
C. Flotho et al.
LEUKEMIA (2009)
RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription
E. Reed-Inderbitzin et al.
ONCOGENE (2006)
Induction of gene expression by 5-Aza-2 '-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms
K Schmelz et al.
LEUKEMIA (2005)
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach
D Gius et al.
CANCER CELL (2004)
Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing™
J Tost et al.
BIOTECHNIQUES (2003)
Demethylase activity is directed by histone acetylation
N Cervoni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
